CeGaT GmbH

@CeGaT_GmbH

CeGaT GmbH is a world leader in gene analyses for a wide range of medical, research, and pharmaceutical applications.

Tübingen, Germany
Vrijeme pridruživanja: rujan 2016.

Tweetovi

Blokirali ste korisnika/cu @CeGaT_GmbH

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CeGaT_GmbH

  1. 4. velj

    CeGaT Exome Xtra - available as of today! This latest diagnostic developed by CeGaT is the most powerful diagnostic tool for patients with complex and unspecific diseases, helping physicians make a .

    Poništi
  2. 4. velj

    Today is World Cancer Day. We would like to help raise awareness of the importance of cancer research - it brings forward the day when hopefully all cancers can be cured.

    Poništi
  3. 3. velj

    Read CeGaT's recent paper on single gene testing: "Novel MECP2 Mutation c.1162_1172del p.Pro388 in Two Patients with Symptoms of Atypical Rett Syndrome."

    Poništi
  4. 30. sij

    CeGaT offers premium - worldwide. As we are committed to long-term, reliable collaborations, regular exchange of information is very important to us. Therefore, we currently meet with our partner Fugene and many medical doctors in Israel - many !

    Poništi
  5. 28. sij

    A few team figures: In the last decade, our team has grown a hundredfold. The age range goes from 23 to 61 years; 69 percent of us are women. Almost one in two has a Ph.D.

    Poništi
  6. 20. sij

    The CeGaT building is only 100 meters away from where CeGaT rented its first labs. Our own building was completed in 2014. And because CeGaT is growing so fast, an extension of the building is planned in the near future.

    Poništi
  7. 17. sij

    Read CeGaT's recent paper on genetic eye diseases: "Ophthalmic features of retinitis pigmentosa in Cohen syndrome caused by pathogenic variants in the VPS13B gene."

    Poništi
  8. 14. sij

    Our first genetic diagnostic panels were the Panel for Epilepsy and the Panel for Eye Diseases, covering in total 155 genes in 2010. After many updates, according to progress, they include more than 1000 genes in 2020

    Poništi
  9. proslijedio/la je Tweet
    29. pro 2019.

    Despite having no cure, an early diagnostic test could significantly improve the quality of life for the 10 million people living with Parkinson’s Disease. Neuroscientists think they might be on the right track:

    Poništi
  10. proslijedio/la je Tweet
    16. pro 2019.

    Learning More About the Migration of Metastatic Cancer Cells | Cancer cells want to conserve energy as they migrate to different parts of the body, new work has shown.

    Poništi
  11. 9. sij

    When CeGaT was founded in 2009, we started as a service provider. Today, we support not only physicians and their patients, but also science and the industry with a broad service portfolio.

    Poništi
  12. 7. sij

    A somewhat unusual set of figures for the : Last year, we consumed over 400 kg of and over 1.5 tons of in the office. That is over 2 kg of coffee and over 7.5 kg of fruit per person.

    Poništi
  13. 7. sij

    2019 was special for us: It marked the 10th anniversary of CeGaT. We are grateful for the experiences we made and proud of what we have achieved. Reason enough to look back and share a few facts with you that you probably did not know yet.

    Poništi
  14. 23. pro 2019.
    Poništi
  15. 12. pro 2019.

    Read CeGaT's recent paper on development : "Novel synonymous and missense variants in FGFR1 causing Hartsfield syndrome."

    Poništi
  16. 6. pro 2019.

    CeGaT has updated the Panel for according to scientific findings and increased its sensitivity. 30 new that have been identified in studies as possible causes of are now included in the panel's gene sets.

    Poništi
  17. 4. pro 2019.

    Greetings from ! We are currently at the 2019 in Basel. Meet us and learn more about CeGaT’s product portfolio.

    Poništi
  18. 3. pro 2019.

    CeGaT has expanded its business unit for the realization of projects: “Research and Pharmas Solutions” offers a broad portfolio of services and tumor analyses to generate the data basis for clinical studies and innovations.

    Poništi
  19. proslijedio/la je Tweet

    Genetic conditions may increase the risk of stomach cancer, such as a mother, father, sister, or brother who has had stomach cancer, having Type A blood, Li-Fraumeni syndrome, Familial adenomatous polyposis (FAP) or Lynch syndrome.

    Poništi
  20. 28. stu 2019.

    CeGaT is at the 16º Congresso Nacional de Oncologia. It is taking place in , Portugal, from November 28–30, 2019. Come and talk to Sami Azrak, PhD about CeGaT's .

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·